Mahesh Lingaraju

Mahesh Lingaraju is a Development Scientist at Novo Nordisk since December 2024, with prior experience as a Senior Scientist at CRELUX, where Mahesh established expression and purification pipelines for membrane proteins and supported early-stage drug discovery through tailored gene-to-protein workflows. At the Max Planck Institute for Biochemistry, Mahesh contributed to significant structural biology projects as a Postdoctoral Researcher and gained extensive experience during doctoral studies in Structural Biology. Mahesh's academic background includes a PhD from Ludwig-Maximilians-Universität München, an MS from Illinois Institute of Technology, and a BPharm from Jawaharlal Nehru Technological University, emphasizing expertise in various biophysical techniques and protein characterization.